Kenneth B Roberts, MD

Professor of Therapeutic Radiology; Director, Pediatric Radiotherapy Program; Associate Chief and Medical Director for Radiation Oncology at Shoreline Medical Center, Yale-New Haven Hospital

Clinical Interests

  • Radiation Oncology

Patient Care

Accepts new patients? Yes
Patient Type: Adult; Child
Referrals: From patients or physicians

Patient Care Organizations

Therapeutic Radiology: Gastrointestinal Radiotherapy | Pediatric Radiotherapy | Prostate & Genitourinary Radiotherapy | Shoreline Medical Center | Spine Radiosurgery

Cancer Center: Brain Tumor Program | Gastrointestinal Cancers Program | Gynecologic Oncology Program | Hematology Program | Pediatric Hematology & Oncology Program

Yale Medicine

Office of Cooperative Research

Board Certifications

  • Internal Medicine AB of Internal Medicine (1987)

  • Medical Oncology AB of Internal Medicine (1989)

  • Radiation Oncology AB of Radiology (1995)

Clinical Trials

Conditions Study Title
Other Respiratory and Intrathoracic Organs, Other Skin, Other Urinary, Ovary, Pancreas, Prostate, Rectum, Small Intestine, Soft Tissue, Stomach, Thyroid, Pediatrics, Anus, Bladder, Bones and Joints, Brain and Nervous System, Breast - Female, Breast - Male, Cervix Uteri, Colon, Corpus Uteri, Esophagus, Eye and Orbit, Hodgkin's Lymphoma, Kaposi's sarcoma, Kidney, Larynx, Lip, Oral Cavity and Pharynx, Liver, Lung, Melanoma, skin, Mycosis Fungoides, Non-Hodgkin's Lymphoma, Other Digestive Organ, Other Endocrine System, Other Female Genital, Other Male Genital A Phase I/II Study of Pembrolizumab (MK-3475) in Children With Advanced Melanoma or a PD-L1 Positive Advanced, Relapsed or Refractory Solid Tumor or Lymphoma (KEYNOTE-051)
Myeloid and Monocytic Leukemia, Pediatrics Gemtuzumab Ozogamicin (Mylotarg (Registered)) Expanded Access Protocol For Treatment Of Patients In The United States With Relapsed/Refractory Acute Myelogenous Leukemia Who May Benefit From Treatment And Have No Access To Other Comparable/Alternative Therapy
Brain and Nervous System, Pediatrics A Clinical and Molecular Risk-Directed Therapy for Newly Diagnosed Medulloblastoma
Bones and Joints, Pediatrics A Phase 2 Study of Human-Mouse Chimeric Anti-Disialoganglioside Monoclonal Antibody ch14.18 (Dinutuximab, NSC# 764038) in Combination With Sargramostim (GM-CSF) in Patients With Recurrent Osteosarcoma
Leukemia, other A Phase I, Open-label, Adaptive Dose-escalation, Multicenter Study to Evaluate the Tolerability, Safety, Pharmacokinetics, and Anti-tumor Activity of ADCT-402 in Patients With Relapsed or Refractory B-cell Lineage Acute Lymphoblastic Leukemia (B-ALL)
Bones and Joints, Brain and Nervous System, Eye and Orbit, Hodgkin's Lymphoma, Kidney, Leukemia, other, Liver, Lymphoid Leukemia, Myeloid and Monocytic Leukemia, Non-Hodgkin's Lymphoma, Other Digestive Organ, Other Endocrine System, Other Female Genital, Other Male Genital, Other Respiratory and Intrathoracic Organs, Other Skin, Other Urinary, Ovary, Small Intestine, Soft Tissue, Pediatrics The Project: Every Child Protocol: A Registry, Eligibility Screening, Biology and Outcome Study
Non-Hodgkin's Lymphoma A Phase I/II Study of Intratumoral G100 Therapy in Patients With Or Without Pembrolizumab In Patients With Follicular Non-Hodgkin's Lymphoma
Leukemia, not otherwise specified, Pediatrics Risk-Stratified Randomized Phase III Testing of Blinatumomab in First Relapse of Childhood B-Lymphoblastic Leukemia (B-ALL)
Brain and Nervous System, Phase I, Pediatrics A Study Comparing Two Carboplatin Containing Regimens for Children and Young Adults With Previously Untreated Low Grade Glioma
Hodgkin's Lymphoma, Pediatrics A Randomized Phase III Study of Brentuximab Vedotin (SGN-35) for Newly Diagnosed High-Risk Classical Hodgkin Lymphoma (cHL) in Children and Adolescents
Soft Tissue, Pediatrics Radiation Therapy With or Without Combination Chemotherapy or Pazopanib Hydrochloride Before Surgery in Treating Patients With Newly Diagnosed Non-Rhabdomyosarcoma Soft Tissue Sarcomas That Can Be Removed by Surgery
Brain and Nervous System, Pediatrics Response and Biology-Based Risk Factor-Guided Therapy in Treating Younger Patients With Non-high Risk Neuroblastoma
Lymphoid Leukemia, Pediatrics Combination Chemotherapy With or Without Bortezomib in Treating Younger Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or Stage II-IV T-Cell Lymphoblastic Lymphoma
Myeloid and Monocytic Leukemia, Pediatrics Bortezomib and Sorafenib Tosylate in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia
Lymphoid Leukemia, Pediatrics Neuropsychological and Behavioral Testing in Younger Patients With Cancer
Lymphoid Leukemia, Pediatrics Risk-Adapted Chemotherapy in Treating Younger Patients With Newly Diagnosed Standard-Risk Acute Lymphoblastic Leukemia or Localized B-Lineage Lymphoblastic Lymphoma
Bones and Joints, Brain and Nervous System, Hodgkin's Lymphoma, Kidney, Leukemia, not otherwise specified, Leukemia, other, Lymphoid Leukemia, Myeloid and Monocytic Leukemia, Non-Hodgkin's Lymphoma, Other Male Genital, Soft Tissue, Pediatrics Enrollment on the Childhood Cancer Research Network (CCRN) of the Children s Oncology Group
Soft Tissue, Pediatrics Collecting and Storing Tissue, Blood, and Bone Marrow Samples From Patients With Rhabdomyosarcoma or Other Soft Tissue Sarcoma
Rectum Pilot Trial of KD018 With Neo-Adjuvant Concurrent Chemo-Radiation Therapy in Patients With Locally Advanced Rectal Cancer

Edit this profile

Contact Info

Kenneth B Roberts, MD
Patient Care Locations
Yale Therapeutic RadiologySmilow Cancer Hospital at Yale - New Haven
35 Park Street, Ste Lower Level

New Haven, CT 06511
View on map...
Yale Therapeutic Radiology-GuilfordYale-New Haven Shoreline Medical Center
111 Goose Lane

Guilford, CT 06437
View on map...
Office Location
Yale Therapeutic RadiologyHunter Building
15 York Street, Ste HRT 133

New Haven, CT 06510
View on map...
Mailing Address
PO Box 208040
New Haven, CT 06520-8040